home / stock / inzy / inzy short
Short Information | Inozyme Pharma Inc. (NASDAQ:INZY)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,487,927 |
Total Actual Volume | 7,186,484 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 74,396 |
Average Short Percentage | 21.41% |
Is there a INZY Short Squeeze or Breakout about to happen?
See the INZY Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $4.46 | $4.49 | $4.55 | $4.43 | 197,852 | 53,358 | 26.97% |
07-02-2024 | $4.61 | $4.42 | $4.665 | $4.32 | 505,123 | 127,361 | 25.21% |
07-01-2024 | $4.45 | $4.41 | $4.51 | $4.345 | 393,671 | 56,959 | 14.47% |
06-28-2024 | $4.53 | $4.46 | $4.535 | $4.39 | 1,055,760 | 51,238 | 4.85% |
06-27-2024 | $4.43 | $4.52 | $4.58 | $4.405 | 182,863 | 36,185 | 19.79% |
06-26-2024 | $4.37 | $4.42 | $4.47 | $4.35 | 260,294 | 56,871 | 21.85% |
06-25-2024 | $4.45 | $4.37 | $4.52 | $4.34 | 476,820 | 144,547 | 30.31% |
06-24-2024 | $4.51 | $4.48 | $4.66 | $4.435 | 384,287 | 116,072 | 30.2% |
06-21-2024 | $4.38 | $4.45 | $4.4804 | $4.38 | 617,483 | 161,320 | 26.13% |
06-20-2024 | $4.35 | $4.4 | $4.445 | $4.335 | 509,565 | 170,113 | 33.38% |
06-18-2024 | $4.59 | $4.4 | $4.62 | $4.24 | 430,297 | 97,641 | 22.69% |
06-17-2024 | $4.72 | $4.6 | $4.72 | $4.58 | 214,230 | 50,629 | 23.63% |
06-14-2024 | $4.76 | $4.74 | $4.8 | $4.64 | 218,848 | 40,243 | 18.39% |
06-13-2024 | $5 | $4.85 | $5.07 | $4.73 | 290,144 | 70,920 | 24.44% |
06-12-2024 | $4.85 | $5 | $5.04 | $4.837 | 281,090 | 46,791 | 16.65% |
06-11-2024 | $4.75 | $4.72 | $4.78 | $4.66 | 237,400 | 38,442 | 16.19% |
06-10-2024 | $4.61 | $4.77 | $4.79 | $4.57 | 261,890 | 50,380 | 19.24% |
06-07-2024 | $4.74 | $4.63 | $4.835 | $4.61 | 245,112 | 34,115 | 13.92% |
06-06-2024 | $4.83 | $4.81 | $4.86 | $4.68 | 201,555 | 36,743 | 18.23% |
06-05-2024 | $4.77 | $4.85 | $4.88 | $4.64 | 222,200 | 47,999 | 21.6% |
News, Short Squeeze, Breakout and More Instantly...
BOSTON, July 02, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal prolifer...
BOSTON, June 21, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferatio...
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation...